Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 32Gastrointestinal 24Other hematologic neoplasm 13Head & Neck 8Thoracic 6Lymphoid 5Sarcoma 3Plasma cell 3Gynecologic 3Classical hematology 3Myeloid 2Other neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Precancerous Conditions 213Lymphoma 47Leukemia 46Multiple Myeloma 44Leukemia, Lymphocytic, Chronic, B-Cell 42Neoplasms, Plasma Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Monoclonal Gammopathy of Undetermined Significance 39Lymphoma, Non-Hodgkin 38Lymphoma, Mantle-Cell 37Lymphoma, Large-Cell, Immunoblastic 37Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Myelodysplastic Syndromes 36Burkitt Lymphoma 36Lymphoma, B-Cell, Marginal Zone 35Leukemia, Myeloid, Acute 35Hodgkin Disease 35Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 34Myeloproliferative Disorders 34Immunoglobulin Light-chain Amyloidosis 33Waldenstrom Macroglobulinemia 32Immunoblastic Lymphadenopathy 32Uterine Cervical Neoplasms 31Lymphoma, Large-Cell, Anaplastic 31Primary Myelofibrosis 30Thrombocythemia, Essential 29Leukemia, Hairy Cell 29Leukemia, Biphenotypic, Acute 29Uterine Cervical Dysplasia 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Other neoplasm × Clear all
NCT05103293 2023-12-27

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Zhejiang Cancer Hospital

Phase 2 Completed
86 enrolled
BreastOther neoplasm

Pathologic Complete Response, Breast Neoplasms, Pathological Conditions, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡